These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 22248821

  • 1. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
    Boudreau EF, Josleyn M, Ullman D, Fisher D, Dalrymple L, Sellers-Myers K, Loudon P, Rusnak J, Rivard R, Schmaljohn C, Hooper JW.
    Vaccine; 2012 Mar 02; 30(11):1951-8. PubMed ID: 22248821
    [Abstract] [Full Text] [Related]

  • 2. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW, Moon JE, Paolino KM, Newcomer R, McLain DE, Josleyn M, Hannaman D, Schmaljohn C.
    Clin Microbiol Infect; 2014 May 02; 20 Suppl 5():110-7. PubMed ID: 24447183
    [Abstract] [Full Text] [Related]

  • 3. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters.
    Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, Schmaljohn C.
    Vaccine; 2008 Sep 19; 26(40):5177-81. PubMed ID: 18482782
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
    Li Z, Zeng H, Wang Y, Zhang Y, Cheng L, Zhang F, Lei Y, Jin B, Ma Y, Chen L.
    Hum Vaccin Immunother; 2017 Apr 03; 13(4):802-807. PubMed ID: 27824286
    [Abstract] [Full Text] [Related]

  • 8. Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.
    Brocato RL, Josleyn MJ, Wahl-Jensen V, Schmaljohn CS, Hooper JW.
    Clin Vaccine Immunol; 2013 Feb 03; 20(2):218-26. PubMed ID: 23239797
    [Abstract] [Full Text] [Related]

  • 9. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
    Hooper JW, Custer DM, Thompson E, Schmaljohn CS.
    J Virol; 2001 Sep 03; 75(18):8469-77. PubMed ID: 11507192
    [Abstract] [Full Text] [Related]

  • 10. [A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y, Xu X, Liu W, Deng X, Weng S, Zhou W, Wang Q, Chen L, Fang L, Xu Z, Yan Q, Liu W, Dong G, Gu H, Yu Y, Xu Z.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov 03; 33(6):340-2. PubMed ID: 11864504
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.
    Song JY, Woo HJ, Cheong HJ, Noh JY, Baek LJ, Kim WJ.
    Vaccine; 2016 Mar 04; 34(10):1289-95. PubMed ID: 26826547
    [Abstract] [Full Text] [Related]

  • 13. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR, Mendoza JM, Spik KW, Badger C, Gomez AF, Schmaljohn CS, Sardesai NY, Broderick KE.
    Hum Vaccin Immunother; 2014 Mar 04; 10(10):3039-47. PubMed ID: 25483486
    [Abstract] [Full Text] [Related]

  • 14. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans.
    Zhu ZY, Tang HY, Li YJ, Weng JQ, Yu YX, Zeng RF.
    Chin Med J (Engl); 1994 Mar 04; 107(3):167-70. PubMed ID: 7916278
    [Abstract] [Full Text] [Related]

  • 15. [Immunogenicity of N-protein of Puumala hantavirus for noninbred mice in the intramuscular administration of its gene DNA].
    Chubukova OV, Khasanova SS, Nikonorov IuM, Kulagin VF, Chemeris AV, Vakhitov VA.
    Vopr Virusol; 2008 Mar 04; 53(4):38-41. PubMed ID: 18756816
    [Abstract] [Full Text] [Related]

  • 16. [Serological surveillance on vaccine against hemorrhagic fever with renal syndrome].
    Gong ZY, Weng JQ, Zhao ZY, Chen YT, Zhu AG, Fu GM, Fang CF, Zhu ZY, Chen EF, Wang CZ, Wang W, Lei LH, Wang Z.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May 04; 25(5):400-2. PubMed ID: 15231163
    [Abstract] [Full Text] [Related]

  • 17. [Passage adaptability of candidate strains for hemorrhagic fever with renal syndrome purified vaccine in Vero cells and their immunogenicity].
    Chen W, Xue CF, Liu JQ, Li ZY, Fan YX, Xu L, Liao H.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun 04; 17(2):129-32. PubMed ID: 12869992
    [Abstract] [Full Text] [Related]

  • 18. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus.
    Chu YK, Jennings GB, Schmaljohn CS.
    J Virol; 1995 Oct 04; 69(10):6417-23. PubMed ID: 7666542
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Specific humoral reaction of hemorrhagic fever with renal syndrome (HFRS) patients in China to recombinant nucleocapsid proteins from European hantaviruses.
    Xiong HR, Li Q, Chen W, Liu DY, Ling JX, Liu J, Liu YJ, Zhang Y, Yang ZQ.
    Eur J Clin Microbiol Infect Dis; 2011 May 04; 30(5):645-51. PubMed ID: 21222012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.